Skip to content

Higher levels of adherence to hepatitis C therapy improve treatment outcomes in people with hepatitis C and HIV

Global evidence of lower adherence to ARVs after giving birth

Near-perfect adherence needed to suppress cell-associated HIV

"Treatment partners" improve short-term virologic outcomes in those starting HIV therapy

Are antiretroviral switch or simplification studies of benefit for patients?

Australians find that money problems lead to poorer adherence to HIV therapy

Community-based support aids retention, adherence and treatment response

Second-line HIV therapy effective and durable in South Africa, and adherence support could improve rates of viral suppression

Active injecting drug users must be provided with adherence support when they start HIV therapy